Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
Qilu was awarded for two products
Shandong provincial Party committee and provincial government held provincial science and technology awarding meeting in Jinan on Feb.16.
Qilu Pharma won provincial scientific and technological progress first prize for34 achievements, including Pemetrexed disodium.Pemetrexed Disodium developped by Qilu pharma is new into clinical, multitargeted and folic acid resistance oncology drugs and used for the treatment of lung cancer,tumors of the skin between pleura and so on. It is recognized as oncology drugs with most clinical value this year.
The state council of the communist party held national science and technology awarding meeting in Beijing on Feb.14. Qilu Pharma won national science and technology progress second prize for Recombinant human interleukin (11) development and key technology industrialization.
The achievement of the prize is the high recognition for the technology,product quality and market performance of Recombinant human interleukin (11) from the country.It is the result of development strategy implement and the scientific research team effort and it is the affirmation of the overall strength of our company.